Literature DB >> 3061440

A phase II study of carboplatin in adenocarcinoma of the oesophagus.

A Steel1, M H Cullen, P W Robertson, H R Matthews.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1988        PMID： 3061440      PMCID： PMC2246802          DOI： 10.1038/bjc.1988.249

Source DB:  PubMed          Journal:  Br J Cancer        ISSN： 0007-0920            Impact factor:   7.640


× No keyword cloud information.
  3 in total

1.  The determinatio of the number of patients required in a preliminary and a follow-up trial of a new chemotherapeutic agent.

Authors:  E A GEHAN
Journal:  J Chronic Dis       Date:  1961-04

2.  Reporting results of cancer treatment.

Authors:  A B Miller; B Hoogstraten; M Staquet; A Winkler
Journal:  Cancer       Date:  1981-01-01       Impact factor: 6.860

3.  Carboplatin: a new platinum analog in the treatment of epidermoid carcinoma of the esophagus.

Authors:  C Sternberg; D Kelsen; M Dukeman; L Leichman; R Heelan
Journal:  Cancer Treat Rep       Date:  1985-11
  3 in total
  2 in total

1.  Phase II study of mitomycin, ifosfamide and cisplatin in adenocarcinoma of the oesophagus.

Authors:  S M Allen; J P Duffy; S J Darnton; M H Cullen; H R Matthews
Journal:  Cancer Chemother Pharmacol       Date:  1996       Impact factor: 3.333

2.  Cisplatin and etoposide in oesophageal cancer: a phase II study. Rotterdam Oesophageal Tumour Study Group.

Authors:  T C Kok; A Van der Gaast; J Dees; W M Eykenboom; H Van Overhagen; G Stoter; H W Tilanus; T A Splinter
Journal:  Br J Cancer       Date:  1996-09       Impact factor: 7.640
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.